Next Article in Journal / Special Issue
Socio-Economic Variation in Price Minimizing Behaviors: Findings from the International Tobacco Control (ITC) Four Country Survey
Previous Article in Journal
Toxicity of Neurons Treated with Herbicides and Neuroprotection by Mitochondria-Targeted Antioxidant SS31
Previous Article in Special Issue
Lysyl Oxidase, A Critical Intra- and Extra-Cellular Target in the Lung for Cigarette Smoke Pathogenesis
Int. J. Environ. Res. Public Health 2011, 8(1), 222-233; doi:10.3390/ijerph8010222
Article

Usage Patterns of Stop Smoking Medications in Australia, Canada, the United Kingdom, and the United States: Findings from the 2006–2008 International Tobacco Control (ITC) Four Country Survey

1,* , 1
, 1
, 2
, 3,4
, 5
, 6
 and 1
Received: 11 December 2010; in revised form: 14 January 2011 / Accepted: 15 January 2011 / Published: 20 January 2011
(This article belongs to the Special Issue Tobacco Smoking: Public Health, Science and Policy)
View Full-Text   |   Download PDF [224 KB, uploaded 19 June 2014]
Abstract: Varenicline is a new prescription stop smoking medication (SSM) that has been available in the United States since August 1, 2006, in the United Kingdom and other European Union countries since December 5, 2006, in Canada since April 12, 2007, and in Australia since January 1, 2008. There are few population-based studies that have examined use rates of varenicline and other stop smoking medications. We report data from the ITC Four Country survey conducted with smokers in the US, UK, Canada, and Australia who reported an attempt to quit smoking in past year in the 2006 survey (n = 4,022 participants), 2007 (n = 3,790 participants), and 2008 surveys (n = 2,735 participants) Respondents reported use of various stop smoking medications to quit smoking at each survey wave, along with demographic and smoker characteristics. The self-reported use of any stop smoking medication has increased significantly over the 3 year period in all 4 countries, with the sharpest increase occurring in the United States. Varenicline has become the second most used stop smoking medication, behind NRT, in all 4 countries since being introduced. Between 2006 and 2008, varenicline use rates increased from 0.4% to 21.7% in the US, 0.0% to 14.8% in Canada, 0.0% to 14.5% in Australia, and 0.0% to 4.4% in the UK. In contrast, use of NRT and bupropion remained constant in each country. Males and non-whites were significantly less likely to report using any SSM, while more educated smokers were significantly more likely to use any SSM, including varenicline. Our findings suggest that the introduction of varenicline led to an increase in the number of smokers who used evidence-based treatment during their quit attempts, rather than simply gaining market share at the expense of other medications. From a public health perspective, messages regarding increased success rates among medication users and the relative safety of stop smoking medications should be disseminated widely so as to reach all smokers of all socioeconomic classifications equally.
Keywords: tobacco cessation; ITC Survey; varenicline tobacco cessation; ITC Survey; varenicline
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Fix, B.V.; Hyland, A.; Rivard, C.; McNeill, A.; Fong, G.T.; Borland, R.; Hammond, D.; Cummings, K.M. Usage Patterns of Stop Smoking Medications in Australia, Canada, the United Kingdom, and the United States: Findings from the 2006–2008 International Tobacco Control (ITC) Four Country Survey. Int. J. Environ. Res. Public Health 2011, 8, 222-233.

AMA Style

Fix BV, Hyland A, Rivard C, McNeill A, Fong GT, Borland R, Hammond D, Cummings KM. Usage Patterns of Stop Smoking Medications in Australia, Canada, the United Kingdom, and the United States: Findings from the 2006–2008 International Tobacco Control (ITC) Four Country Survey. International Journal of Environmental Research and Public Health. 2011; 8(1):222-233.

Chicago/Turabian Style

Fix, Brian V.; Hyland, Andrew; Rivard, Cheryl; McNeill, Ann; Fong, Geoffrey T.; Borland, Ron; Hammond, David; Cummings, K. Michael. 2011. "Usage Patterns of Stop Smoking Medications in Australia, Canada, the United Kingdom, and the United States: Findings from the 2006–2008 International Tobacco Control (ITC) Four Country Survey." Int. J. Environ. Res. Public Health 8, no. 1: 222-233.


Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert